{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:47Z","timestamp":1753891847880,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Thymic carcinomas are exceedingly rare and very aggressive malignancies of the anterior mediastinum. While thymomas exhibit a high association with paraneoplastic syndromes, these phenomena are a rarity in thymic carcinomas. In general, acanthotic syndromes such as acroceratosis neoplastica and acanthosis nigricans maligna are commonly observed as paraneoplastic phenomena in patients with carcinomas. In contrast, psoriasis vulgaris, another acanthotic disease, rarely occurs as a paraneoplasia. We report the case of a 36-year-old patient with progressive thymic carcinoma (undifferentiated carcinoma, T3N2M1a) and paraneoplastic psoriasis occurring ten months before the initial diagnosis of the carcinoma. Over the course of the disease, new psoriatic flares heralded relapse or progression of the carcinoma. To our knowledge, this is the first reported case of paraneoplastic psoriasis in thymic carcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2023.1218517","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T11:58:49Z","timestamp":1692273529000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Paraneoplastic psoriasis in thymic carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Lucas","family":"Mix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max-Felix","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang Andreas","family":"Bethge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Forchhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Krumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.04.012","article-title":"Thymic carcinoma with multiple paraneoplastic disorders","volume":"362","author":"Alexakou","year":"2021","journal-title":"Am J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100323","DOI":"10.1016\/j.jtocrr.2022.100323","article-title":"Autoimmune disease in patients with advanced thymic epithelial tumors","volume":"3","author":"Singhal","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-012-0144-x","article-title":"Paraneoplastic dermatomyositis as presentation of thymic carcinoma","volume":"61","author":"Dell\u2019Amore","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B7","first-page":"68","article-title":"Dermatomyositis as first clinical appearance for a thymic epidermoid cell carcinoma","volume":"81","author":"Iacovelli","year":"2010","journal-title":"Acta Biomed"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.3935","article-title":"Scleromyxedema: a cutaneous paraneoplastic syndrome associated with thymic carcinoma","volume":"30","author":"Chan","year":"2012","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbr.2017.08.021","article-title":"Leser-tr\u00e9lat sign secondary to thymic carcinoma","volume":"54","author":"Mendes","year":"2018","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"000780","DOI":"10.12890\/2018_000780","article-title":"Thymic carcinoma associated with cerebellar degeneration","volume":"5","author":"Cuartero","year":"2018","journal-title":"Eur J Case Rep Intern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21282","article-title":"Thymic carcinoma in myasthenia gravis developing years after thymectomy","volume":"40","author":"Katzberg","year":"2009","journal-title":"Muscle Nerve"},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of Malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J Thorac Oncol"},{"article-title":"WHO classification of tumours editorial board. Thoracic tumours","volume-title":"WHO Classification of Tumors, 5","year":"","key":"B13"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-008-0081-1","article-title":"Paraneoplastic syndromes in thymoma: an immunological perspective","volume":"9","author":"Nelson","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12895","article-title":"Psoriasis and infection. A clinical practice narrative","volume":"60","author":"Rademaker","year":"2019","journal-title":"Australas J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.123487","article-title":"Herpes simplex virus-induced psoriatic flares in a patient previously treated with tamoxifen: a follow-up","volume":"46","author":"Boyd","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb02467.x","article-title":"Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections","volume":"118","author":"Henderson","year":"1988","journal-title":"Br J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16367","article-title":"Rituximab-induced psoriasis in a patient with pemphigus foliaceous: A case report and literature review","volume":"49","author":"Charoenpipatsin","year":"2022","journal-title":"J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb02236.x","article-title":"Prevalence of skin and other cancers in patients with psoriasis","volume":"18","author":"Bhate","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.09.014","article-title":"Paraneoplastic psoriasis in a patient with prostate cancer","volume":"4","author":"Cadmus","year":"2018","journal-title":"JAAD Case Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_427_16","article-title":"Branch duct-type intraductal papillary mucinous neoplasm presenting as paraneoplastic small plaque para-psoriasis","volume":"9","author":"Philips","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_518_20","article-title":"Malignant Acanthosis nigricans as a paraneoplastic precursor of metastatic cholangiocarcinoma","volume":"12","author":"Stevens","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.642","article-title":"Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature","volume":"119","author":"Krawczyk","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000521269","article-title":"Bazex syndrome associated with squamous cell carcinoma of the lip: A rare paraneoplastic acrokeratosis with nail dystrophy","volume":"8","author":"Gaurav","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1979.04010070002004","article-title":"Munro microabscess: let\u2019s spell it right","volume":"115","author":"King","year":"1979","journal-title":"Arch Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0738-081X(93)90079-R","article-title":"Bazex\u2019 syndrome","volume":"11","author":"Bolognia","year":"1993","journal-title":"Clin Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0190-9622(94)70128-8","article-title":"Acanthosis nigricans","volume":"31","author":"Schwartz","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14507_g","article-title":"Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidit\u00e4t","volume":"19","author":"Nast","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"B34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","article-title":"Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor","volume":"60","author":"Belum","year":"2016","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2017.10.003","article-title":"Anti-PD1\/PDL1 induced psoriasis","volume":"41","author":"Voudouri","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.105","article-title":"Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features","volume":"83","author":"Ellis","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000900","article-title":"Cutaneous eruptions in patients receiving immune checkpoint blockade: clinicopathologic analysis of the nonlichenoid histologic pattern","volume":"41","author":"Kaunitz","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000121","article-title":"Severe psoriasis flare after anti-programmed death ligand 1 (PD-L1) therapy for metastatic non-small cell lung cancer (NSCLC)","volume":"39","author":"Chia","year":"2016","journal-title":"J Immunother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14011","article-title":"Anti-PD1-induced psoriasis: a study of 21 patients","volume":"31","author":"Bonigen","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09348.x","article-title":"Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac129","article-title":"Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review","volume":"61","author":"Vincken","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12755","article-title":"A case of rupioid psoriasis exacerbated by systemic glucocorticosteroids","volume":"54","author":"Bonciani","year":"2015","journal-title":"Int J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2011.07668.x","article-title":"Therapy of psoriasis in childhood and adolescence - a German expert consensus","volume":"9","author":"Sticherling","year":"2011","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1218517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T11:58:52Z","timestamp":1692273532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1218517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":44,"alternative-id":["10.3389\/fonc.2023.1218517"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1218517","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"article-number":"1218517"}}